Emerging concepts in the therapy of mitochondrial disease

被引：86

作者：

Viscomi, Carlo ^{[1
,2
]}

Bottani, Emanuela ^{[2
]}

Zeviani, Massimo ^{[1
,2
]}

机构：

[1] Fdn Carlo Besta Inst Neurol IRCCS, Unit Mol Neurogenet, I-20133 Milan, Italy

[2] MRC, Mitochondrial Biol Unit, Cambridge CB2 0XY, England

来源：

BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS | 2015年 / 1847卷 / 6-7期

关键词：

Mitochondrion; Experimental therapy; Oxidative phosphorilation; Mitochondrial respiratory chain; Mitochondrial disease; Animal model; TRANSFER-RNA SYNTHETASE; CORRECTS BIOCHEMICAL DERANGEMENTS; OPTIMIZED ALLOTOPIC EXPRESSION; HEREDITARY OPTIC NEUROPATHY; RESPIRATORY-CHAIN DEFECTS; IN-VITRO SUPPLEMENTATION; LARGE-SCALE DELETIONS; GENE-THERAPY; COMPLEX-I; ALTERNATIVE OXIDASE;

D O I：

10.1016/j.bbabio.2015.03.001

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Mitochondrial disorders are an important group of genetic conditions characterized by impaired oxidative phosphorylation. Mitochondrial disorders come with an impressive variability of symptoms, organ involvement, and clinical course, which considerably impact the quality of life and quite often shorten the lifespan expectancy. Although the last 20 years have witnessed an exponential increase in understanding the genetic and biochemical mechanisms leading to disease, this has not resulted in the development of effective therapeutic approaches, amenable of improving clinical course and outcome of these conditions to any significant extent. Therapeutic options for mitochondrial diseases still remain focused on supportive interventions aimed at relieving complications. However, new therapeutic strategies have recently been emerging, some of which have shown potential efficacy at the pre-clinical level. This review will present the state of the art on experimental therapy for mitochondrial disorders. Crown Copyright (C) 2015 Published by Elsevier B.V.

引用

页码：544 / 557

页数：14

共 165 条

[61] Allotopic expression of a mitochondrial alternative oxidase confers cyanide resistance to human cell respiration [J].

Hakkaart, GAJ ;

Dassa, EP ;

Jacobs, HT ;

Rustin, P .

EMBO REPORTS, 2006, 7 (03) :341-345

[62] Allogeneic stem cell transplantation corrects biochemical derangements in MNGIE [J].

Hirano, M. ;

Marti, R. ;

Casali, C. ;

Tadesse, S. ;

Uldrick, T. ;

Fine, B. ;

Escolar, D. M. ;

Valentino, M. L. ;

Nishino, I. ;

Hesdorffer, C. ;

Schwartz, J. ;

Hawks, R. G. ;

Martone, D. L. ;

Cairo, M. S. ;

DiMauro, S. ;

Stanzani, M. ;

Garvin, J. H., Jr. ;

Savage, D. G. .

NEUROLOGY, 2006, 67 (08) :1458-1460

[63] Defining the action spectrum of potential PGC-1 activators on a mitochondrial and cellular level in vivo [J].

Hofer, Annette ;

Noe, Natalie ;

Tischner, Christin ;

Kladt, Nikolay ;

Lellek, Veronika ;

Schauss, Astrid ;

Wenz, Tina .

HUMAN MOLECULAR GENETICS, 2014, 23 (09) :2400-2415

[64]

HOLT IJ, 1990, AM J HUM GENET, V46, P428

[65] PPARδ, but not PPARα, activates PGC-lα gene transcription in muscle [J].

Hondares, Elayne ;

Pineda-Torra, Ines ;

Iglesias, Roser ;

Staels, Bart ;

Villarroya, Francesc ;

Giralt, Marta .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 354 (04) :1021-1027

[66] Human mitochondrial leucyl tRNA synthetase can suppress non cognate pathogenic mt-tRNA mutations [J].

Hue Tran Hornig-Do ;

Montanari, Arianna ;

Rozanska, Agata ;

Tuppen, Helen A. ;

Almalki, Abdulraheem A. ;

Abg-Kamaludin, Dyg P. ;

Frontali, Laura ;

Francisci, Silvia ;

Lightowlers, Robert N. ;

Chrzanowska-Lightowlers, Zofia M. .

EMBO MOLECULAR MEDICINE, 2014, 6 (02) :183-193

[67] The ketogenic diet increases mitochondrial glutathione levels [J].

Jarrett, Stuart G. ;

Milder, Julie B. ;

Liang, Li-Ping ;

Patel, Manisha .

JOURNAL OF NEUROCHEMISTRY, 2008, 106 (03) :1044-1051

[68] Aerobic training is safe and improves exercise capacity in patients with mitochondrial myopathy [J].

Jeppesen, Tina D. ;

Schwartz, Marianne ;

Olsen, David B. ;

Wibrand, Flemming ;

Krag, Thomas ;

Duno, Morten ;

Hauerslev, Simon ;

Vissing, John .

BRAIN, 2006, 129 :3402-3412

[69] mTOR Inhibition Alleviates Mitochondrial Disease in a Mouse Model of Leigh Syndrome [J].

Johnson, Simon C. ;

Yanos, Melana E. ;

Kayser, Ernst-Bernhard ;

Quintana, Albert ;

Sangesland, Maya ;

Castanza, Anthony ;

Uhde, Lauren ;

Hui, Jessica ;

Wall, Valerie Z. ;

Gagnidze, Arni ;

Oh, Kelly ;

Wasko, Brian M. ;

Ramos, Fresnida J. ;

Palmiter, Richard D. ;

Rabinovitch, Peter S. ;

Morgan, Philip G. ;

Sedensky, Margaret M. ;

Kaeberlein, Matt .

SCIENCE, 2013, 342 (6165) :1524-1528

[70]

Jun AS, 1996, MOL CELL BIOL, V16, P771

← 2 3 4 5 6 7 8 9 10 11 →